Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Feb 16:9:841223.
doi: 10.3389/fmolb.2022.841223. eCollection 2022.

Gut Microbiome and the Role of Metabolites in the Study of Graves' Disease

Affiliations
Review

Gut Microbiome and the Role of Metabolites in the Study of Graves' Disease

Haihua Liu et al. Front Mol Biosci. .

Abstract

Graves' disease (GD) is an autoimmune thyroid disease (AITD), which is one of the most common organ-specific autoimmune disorders with an increasing prevalence worldwide. But the etiology of GD is still unclear. A growing number of studies show correlations between gut microbiota and GD. The dysbiosis of gut microbiota may be the reason for the development of GD by modulating the immune system. Metabolites act as mediators or modulators between gut microbiota and thyroid. The purpose of this review is to summarize the correlations between gut microbiota, microbial metabolites and GD. Challenges in the future study are also discussed. The combination of microbiome and metabolome may provide new insight for the study and put forward the diagnosis, treatment, prevention of GD in the future.

Keywords: autoimmunity; graves’ disease (GD); gut microbiome; metabol(n)omics; metabolites.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
Association between gut microbiota, metabolites, and thyroid autoimmune diseases.

Similar articles

Cited by

References

    1. Al-Majdoub M., Lantz M., Spégel P. (2017). Treatment of Swedish Patients with Graves' Hyperthyroidism Is Associated with Changes in Acylcarnitine Levels. Thyroid 27, 1109–1117. 10.1089/thy.2017.0218 - DOI - PubMed
    1. Arrieta M.-C., Stiemsma L. T., Dimitriu P. A., Thorson L., Russell S., Yurist-Doutsch S., et al. (2015). Early Infancy Microbial and Metabolic Alterations Affect Risk of Childhood Asthma. Sci. Transl. Med. 7, 307ra152. 10.1126/scitranslmed.aab2271 - DOI - PubMed
    1. Bahn R. S. (2003). Pathophysiology of Graves' Ophthalmopathy: The Cycle of Disease. J. Clin. Endocrinol. Metab. 88, 1000–1946. 10.1210/jc.2002-030010 - DOI - PubMed
    1. Bargiel P., Szczuko M., Stachowska L., Prowans P., Czapla N., Markowska M., et al. (2021). Microbiome Metabolites and Thyroid Dysfunction. Jcm 10, 3609. 10.3390/jcm10163609 - DOI - PMC - PubMed
    1. Bunyavanich S., Shen N., Grishin A., Wood R., Burks W., Dawson P., et al. (2016). Early-life Gut Microbiome Composition and Milk Allergy Resolution. J. Allergy Clin. Immunol. 138, 1122–1130. 10.1016/j.jaci.2016.03.041 - DOI - PMC - PubMed

LinkOut - more resources